{
    "title": "Novartis says operating profit to grow again ahead of Sandoz spin off",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11699841/Novartis-says-operating-profit-grow-2023.html",
    "date": "2023-02-01",
    "keywords": [
        "drug",
        "income",
        "market",
        "core",
        "growth",
        "track",
        "business",
        "sandoz",
        "breast",
        "cancer",
        "blood",
        "disorder",
        "burger",
        "wednesday",
        "operating",
        "digit",
        "percentage",
        "year",
        "programme",
        "fy",
        "h2",
        "outlook",
        "detail",
        "basel",
        "range",
        "stagnation",
        "drugmaker",
        "statement",
        "currency",
        "group",
        "heart",
        "failure",
        "entresto",
        "sclerosis",
        "competition",
        "gilenya",
        "novartis",
        "unit",
        "half",
        "part",
        "effort",
        "focus",
        "prescription",
        "therapy",
        "trade",
        "credit",
        "suisse",
        "psoriasis",
        "cosentyx",
        "company",
        "price",
        "guidance",
        "sandozs",
        "inflation",
        "standalone",
        "entity",
        "wider",
        "use",
        "kisqali",
        "iptacopan",
        "astrazenecas",
        "soliris",
        "kesimpta",
        "driver",
        "reporting",
        "josephine",
        "mason",
        "jason"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}